ARTICLE | Deals
July 2 Quick Takes: PE firms swap Parexel in $8.5B takeout; plus Arrowhead, Cerevel, Iterum, Caribou, Beneluxa Initiative
July 3, 2021 2:55 AM UTC
EQT Private Equity and Goldman Sachs Asset Management’s PE unit acquired CRO Parexel International Corp. from Pamplona Capital Management.
In another reminder that safety risks take time to understand in new modalities, Arrowhead Pharmaceuticals Inc. (NASDAQ:ARWR) paused the Phase I/II AROENaC1001 study of RNAi therapy ARO-ENaC in cystic fibrosis patients after detecting unexpected lung inflammation in rats. Arrowhead fell $21.83 (26%) to $63.13 on the news...